Medstar Franklin Square Medical Center

Baltimore, Maryland 21237

9 studies enrolling now · 17 studies all time

What they study most

Breast Cancer, COVID-19, Chronic Migraine, Colorectal Neoplasms, Cutaneous Melanoma, Stage II, Diabetic Foot Ulcer, Episodic Migraine, Flat Epithelia Atypia, Focal Onset Seizures, Hormone Receptor Positive Breast Carcinoma, Humerus Fracture Metastatic Bone Disease, Intraductal Papilloma Without Atypia

Studies at this site

• MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study — Recruiting now
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer — Recruiting now
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults — Recruiting now
• Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries — Recruiting now
• Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
• A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers — Enrolling by invitation
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
• Nudging Effective and Equitable Delivery of Specialty Palliative Care — Enrolling by invitation
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
• The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy — Completed
• Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection — Completed
• A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer — Completed
• Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer — Stopped early
• Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction — Status unconfirmed
• Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus — Completed